Jane Street’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-18,064
Closed -$487K 10452
2022
Q4
$487K Sell
18,064
-44,700
-71% -$1.18M ﹤0.01% 6178
2022
Q3
$1.13M Buy
62,764
+18,443
+42% +$294K ﹤0.01% 5201
2022
Q2
$551K Sell
44,321
-6,076
-12% -$67K ﹤0.01% 6561
2022
Q1
$672K Sell
50,397
-9,276
-16% -$124K ﹤0.01% 6931
2021
Q4
$929K Buy
59,673
+24,591
+70% +$469K ﹤0.01% 6038
2021
Q3
$788K Sell
35,082
-32,211
-48% -$707K ﹤0.01% 6396
2021
Q2
$1.53M Buy
67,293
+3,638
+6% +$76.5K ﹤0.01% 4882
2021
Q1
$1.31M Buy
63,655
+47,915
+304% +$1.09M ﹤0.01% 4920
2020
Q4
$435K Sell
15,740
-71,283
-82% -$1.39M ﹤0.01% 5941
2020
Q3
$1.22M Buy
+87,023
New +$1.62M ﹤0.01% 3755
2020
Q1
Sell
-24,145
Closed -$374K 6195
2019
Q4
$374K Buy
+24,145
New +$243K ﹤0.01% 4026

Other funds holding MYOV

Jane Street's MYOV Position: Q1 2023 in Review

Jane Street sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 18,064 shares — an estimated $487K sold.

Jane Street first reported a position in MYOV in Q4 2019 and held it in 11 quarters. The position peaked at $1.53M in Q2 2021. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Jane Street reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 18,064 Myovant Sciences Ltd. shares in Q1 2023, an estimated $487K.
  • Jane Street first reported a position in Myovant Sciences Ltd. in Q4 2019 and held it in 11 quarters.
  • Jane Street's Myovant Sciences Ltd. position peaked at $1.53M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.